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Background: Cyclin-dependent kinase 5 (Cdk5), which is activated by binding to p35 or p39, is involved in synaptic
plasticity and affects learning and memory formation. In Cdk5 knockout (KO) mice and p35 KO mice, brain
development is severely impaired because neuronal migration is impaired and lamination is disrupted. To avoid
these developmental confounders, we generated inducible CreER-p35 conditional (cKO) mice to study the role of
Cdk5/p35 in higher brain function.
Results: CreER-p35 cKO mice exhibited spatial learning and memory impairments and reduced anxiety-like behavior.
These phenotypes resulted from a decrease in the dendritic spine density of CA1 pyramidal neurons and defective
long-term depression induction in the hippocampus.
Conclusions: Taken together, our findings reveal that Cdk5/p35 regulates spatial learning and memory, implicating
Cdk5/p35 as a therapeutic target in neurological disorders.
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Cyclin-dependent kinase 5 (Cdk5) is a serine/threonine
kinase that is abundant in neuronal cells and is activated
by complexing with p35 or p39. Recent studies have
demonstrated that Cdk5 is critically involved in synaptic
plasticity, a cellular basis of memory formation [1], in
addition to its function in neuronal development [2-5].
At presynaptic terminals, Cdk5 regulates neurotransmitter
release via phosphorylation of presynaptic proteins such
as synapsin I and N-type voltage-gated calcium channels
[6,7]. Alternatively, at postsynaptic dendritic spines, Cdk5
phosphorylates postsynaptic proteins such as postsynaptic
density protein 95 (PSD-95) [8], NMDA receptor subunit
NR2A [9], protein phosphatase inhibitor-1 [10], dopamine-
and cAMP-regulated neuronal phosphoprotein (DARPP-32)
[11], and tropomysin-related kinase B (TrkB) [12]. Moreover,
inducible Cdk5 conditional knockout (cKO) mice show
enhanced synaptic plasticity and improved spatial learning
and memory via an increase in synaptic NR2B subunits of* Correspondence: ohshima@waseda.jp
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unless otherwise stated.NMDA receptors [13]. More recently, it was shown that
disrupting long-term potentiation (LTP) and long-term
depression (LTD) in the hippocampal CA1 of mice lacking
Cdk5 results in the impairment of spatial learning and
memory partly due to the collapse of cAMP signaling
[14]. These two results, however, are likely secondary
consequences of the loss of Cdk5 function as a scaffold
protein [15] and a regulator of other signaling pathways,
respectively. Therefore, the original functions of Cdk5 in
synaptic plasticity and in the phosphorylation of synaptic
proteins remain to be elucidated.
We have previously demonstrated an impairment of
spatial learning and memory, and hippocampal LTD in-
duction in p35 knockout (KO) mice. However, p35KO
mice exhibit reversed cortical lamination of cerebral cor-
tex and mild disorganization of cellular alignment of
CA1 pyramidal neurons and dentate gyrus [3]. These
histological abnormalities in the brain may confound
these results [16]. To further investigate the role of
Cdk5/p35 in higher brain function without histological
abnormalities, we generated inducible p35 conditional
knockout (cKO) mice, in which p35 is deleted in all cells
by breeding p35-flox mice with CreER-mice [17]. We
found that CreER-p35 cKO mice have defective spatiall Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain

























Figure 1 Inducible p35 protein reduction in the CreER-p35 cKO
mouse brain. (A, B) Tamoxifen was administered orally to CreER-p35
cKO mice (black bars, p35 cKO) and p35-flox mice (white bars, control).
1 week after administration, p35 protein was significantly reduced in
CreER-p35 cKO mice when compared with control. Unpaired t-test,
*p < 0.05, ***p < 0.001.
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behavior. We also showed reduced spine density of
pyramidal neurons, reduced sensitivity to synaptic input,
and impaired LTD induction in the hippocampal CA1.
Biochemical analysis revealed no alteration of NR2B
protein in the hippocampi of CreER-p35 cKO mice.
These findings indicate that the kinase function of
Cdk5/p35 is essential for normal synaptic function
and spatial learning and memory.
Results
Reduction of p35 protein in the brains of p35-flox; CreER
mice by oral administration of tamoxifen
To analyze the function of Cdk5/p35 in the adult mouse
brain, we induced Cre activity by oral administration
of tamoxifen at 6 months of age. We fed mice with
3 mg · 40 g−1 body weight tamoxifen for three days
and analyzed protein levels of p35 in different brain
regions of p35-flox; CreER mice after one week. As
shown in Figure 1, we found a significant reduction
of p35 protein levels in all brain regions examined
when compared with tamoxifen-fed p35-flox mice
(hereafter control mice). Therefore, we are able to use
tamoxifen to induce conditional deletion of p35. Protein
levels of Cdk5 in hippocampi of CreER-35 cKO mice
were found comparable with those of control mice
(Additional file 1: Figure S1).
Normal locomotor activity and reduced anxiety-like
behavior in CreER-p35 cKO mice
To evaluate the role of Cdk5/p35 in higher brain function,
we tested control and CreER-p35 cKO mice with behavioral
tests. Using an open field test to investigate locomotor
activity, we found no differences in total distance of
horizontal movements and spending time in center region
of the open field among the two genotypes (Figure 2A).
The anxiety-like behavior of CreER-p35 cKO mice was
assessed with an elevated plus maze (Figure 2B). The
total distance traveled by CreER-p35 cKO mice was a lit-
tle longer than that by control mice. The time CreER-p35
cKO mice spent in the closed arm was significantly shorter
than that in control mice, while CreER-p35 cKO mice
remained in the open arm somewhat longer than control
mice. These results suggest that CreER-p35 cKO mice have
reduced anxiety-like behavior.
Defective spatial learning and memory in CreER-p35 cKO
mice
In a previous study, p35 KO mice exhibited impaired
spatial learning and memory, although these mice
showed some deficits in brain development as well [16].
In order to distinguish between secondary effects due to
altered brain development and clarify the function of
Cdk5/p35 in spatial learning and memory, CreER-p35cKO and control mice were analyzed with the Morris
water maze (Figure 3). Mice swam to find the hidden
platform and escape the water. On the first training day,
the latency to reach the platform was almost the same
between the two genotypes. During the training sessions
for 9 days, the latency to reach the platform significantly
decreased in control mice but not in CreER-p35 cKO
mice (Figure 3A).
The platform was removed after the hidden platform
task, and mice were allowed to swim freely in the probe
test. The time spent in the target quadrant (where the
platform had been formerly located) was significantly
longer than the time spent in the other quadrants for
control mice, while the time spent in the target quadrant
was not different from the time spent in the other quadrants
for CreER-p35 KO mice (Figure 3B). The number of times
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Figure 2 Normal locomotor activity and reduced anxiety-like behavior in CreER-p35 cKO mice (A) Total distance (cm) and percentage
time spent in the center region of the open field in p35-flox (white bars, control, n =6) and CreER-p35 cKO mice (black bars, p35 cKO, n =8). No
difference was observed between these. (B) Total distance (cm) and percentage time spent in closed and open arms in the elevated plus maze
in p35-flox (white bars, control, n =6) and CreER-p35 cKO mice (black bars, p35 cKO, n =8). CreER-p35 cKO mice traveled a similar distance when
compared with control and displayed less anxiety-like behavior. Error bars represent standard error of the mean (S.E.M.). Unpaired t-test, *p < 0.05.
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that by control mice (Figure 3C). CreER-p35 cKO
mice swam almost as far and as fast as control mice
(Figure 3C). In the visible platform test, however, the total
distance swam by CreER-p35 cKO mice was approximately
equal to that by the control mice (Figure 3D). These results
suggest that spatial learning and memory are significantly
impaired in CreER-p35 cKO mice.
Reduction in dendritic spine density in CreER-p35 cKO
mice
To clarify the mechanism underlying the impairment in
spatial learning and memory, we studied the morphology
of Golgi-stained pyramidal neurons in the hippocampal
area CA1 and layer V in the cerebral cortex. We found
that in CreER-p35 cKO mice, dendritic spine density on
the apical dendrites of CA1 pyramidal neurons was
significantly reduced. In addition, spine density on layer V
basal dendrites in the cerebral cortex was significantly
reduced when compared with control mice (Figure 4).
Our findings suggest that the loss of dendritic spines on
CA1 pyramidal neurons contributes to defective spatial
learning and memory.
Impaired synaptic properties in CreER-p35 cKO mice
We examined the basal synaptic transmission of inducible
CreER-p35 cKO mice. The slope of Shaffer collateral-CA1
field excitatory postsynaptic potentials (fEPSPs) wassignificantly reduced (p < 0.05) in CreER-p35 mice
when compared with control mice (Figure 5A), with
no change in presynaptic fiber volley amplitude (Figure 5B).
We did not detect any significant differences in
paired-pulse facilitation (Figure 5C), a form of short-term
presynaptic plasticity. These results suggest that impaired
synaptic transmission in CreER-p35 cKO was not caused
by a presynaptic deficit.
To test whether loss of p35 affects synaptic plasticity, we
next examined if there were any changes in hippocampal
LTD in CreER-p35 cKO mice. LTD in adult mice was
induced using low-frequency stimulation (LFS) combined
with the application of the glutamate transporter
inhibitor, tPDC [18]. To determine if this form of
LTD is NMDAR-dependent, LTD was induced in the
presence of the NMDA blocker, D-AP5. We found
that LTD was significantly blocked by D-AP5, indicating
that LTD is largely NMDAR-dependent (Additional file 2:
Figure S2). We found that LTD induction was significantly
impaired in CreER-p35 cKO mice when compared with
control (Figure 5D; control, 82.1 ± 2.3%; p35 cKO,
98.2 ± 2.3%; unpaired t-test, p =0.0003). We next exam-
ined if LTP was affected in CreER-p35 cKO mice. Using
3× theta-burst stimulations (TBS), we found that there
were no significant LTP differences between genotypes
(Figure 5E). Thus, these results demonstrate that loss of
p35 resulted in a reduction in the postsynaptic response
and selectively affected NMDAR-mediated LTD.
Figure 3 Defective spatial learning and memory in CreER-p35 cKO mice. (A) Latency (s) over 9 testing days in the Morris water maze in
p35-flox (open square, control, n =6) and CreER-p35 cKO mice (closed rhombus, p35 cKO, n =7). The slope of the learning curve was significantly
lower in CreER-p35 cKO mice when compared with control mice (mixed ANOVA test, p =0.027). (B) The probe test after the hidden platform task.
Control mice spent longer in the target quadrant (T) than other quadrants (One-way ANOVA test, p = 0.0054), while CreER-p35 cKO mice did not.
(C) Total distance (cm), the number of crosses over the region where the platform was formerly located, and swimming speed (cm/s) of the
probe test, and total distance (cm) in CreER-p35 cKO and control mice in the visible platform task. CreER-p35 cKO mice crossed the region fewer
times than the control mice, and swam as far and as fast as control mice (unpaired t-test, p = 0.034). (D) No difference was observed in the total
distance travelled in the visible platform task between the two genotypes. Error bars represent S.E.M. Unpaired t-test, *p < 0.05, **p < 0.01.
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CreER-p35 cKO mice
To investigate the molecular mechanisms underlying the
deficits of spatial learning and memory, we performed
biochemical analysis of postsynaptic proteins in the
hippocampi of CreER-p35 cKO and control mice
(Figure 6). GluR1-containing AMPA receptors and
NR2B-containing NMDA receptors are involved in
synaptic plasticity, leading to memory formation. In
CreER-p35 cKO mice, protein levels of GluR1 and NR2B
were not altered in the hippocampi when compared with
that of control mice (Figure 6A). We also found that
the phosphorylation level of pGluR1 (S845), a PKA
phosphorylation site, was not altered, but levels of
pGluR1 (S831), a CaMKII phosphorylation site, were
dramatically elevated in the hippocampi of CreER-p35 cKO
mice when compared with control mice (Figure 6A, B).
When CaMKII is activated, CaMKII autophosphorylates
at T286. We found that the phosphorylation level of
pCaMKII (T286) was significantly elevated in CreER-p35
cKO mice when compared with control mice (Figure 6C).We also analyzed phosphorylation level of CaMKII at
T305, because previous study reported that activated
CaMKII can promote either LTP or LTD depending on
T305/T306 phosphorylation [18]. pCaMKII (T305) was
reduced in CreER-p35 cKO mice, although the difference
was not statistically significant (p =0.338).
CREB is one of the transcriptional factors implicated
in memory formation that is controlled by cAMP signaling.
We found no difference in the phosphorylation level of
pCREB (S133) between CreER-p35 cKO and control mice
(Figure 6D). These results suggest that the impaired spatial
learning and memory and defective NMDAR-dependent
LTD induction observed in CreER-p35 cKO mice are unre-
lated to cAMP signaling and the phosphorylation of CREB.
Discussion
Our findings implicate Cdk5/p35 in spatial learning and
memory, anxiety-like behavior, LTD induction, and the
maintenance of spine density on hippocampal CA1
pyramidal neurons. These phenotypes of CreER-p35 cKO
mice are similar to those of p35 KO mice [16] and
Figure 4 Reduced dendritic spine density on pyramidal neurons in CreER-p35 cKO mice. (A) Representative segments of the dendrites of
pyramidal neurons in the cerebral cortex and hippocampus. Scale bar: 50 μm. (B) Higher magnified images of indicated areas of the dendrites of
pyramidal neurons in the cerebral cortex and in the hippocampus. Scale bar: 10 μm. (C) Dendritic spine density in the cerebral cortex and
hippocampus was significantly decreased in CreER-p35 cKO (p35 cKO, black bars) compared with p35-flox (control, white bars) mice. hip: hippocampus,
cc: cerebral cortex. Error bars represent S.E.M. **p < 0.01, ***p < 0.001.
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findings from inducible Cdk5 cKO mice [13]. In inducible
Cdk5 cKO mice, increased NR2B in the postsynaptic
membrane may lead to unexpected phenotypes that
include improved learning and memory [13]. Thus, the
phenotype of inducible Cdk5 cKO mice did not represent
a loss of Cdk5 kinase function [15]. CaMKIIcre-Cdk5
cKO mice exhibited impaired learning and memory with
impaired cAMP signaling [14]. Since rolipram, an inhibitor
of PDE4 and activator of cAMP signaling, rescued impaired
learning and memory and hippocampal LTP, this pheno-
type is explained by impaired cAMP signaling [14]. In
p35 KO mice, histological abnormalities make it uncer-
tain that the observed phenotypes, including impaired
spatial learning and memory, are caused by Cdk5/p35
loss-of-function of [16]. Our present study clearly supportsthe idea that Cdk5/p35 is required for spatial learning and
memory [16].
Interestingly, defective LTD, but normal LTP in CA1,
and the impairment of spatial learning and memory
were also observed in p35 KO [16] and p35 cKO mice
(Figure 5). In mice lacking GluN2B, also known as NR2B,
pyramidal neurons in the cortex and hippocampal CA1
had defective NMDA-dependent LTD and impaired
spatial learning and memory [19]. However, we found
comparative protein levels of NR2B in the hippocampi of
CreER-p35 cKO mice (Figure 6A). There are several
explanations for impaired induction of LTD with the loss
of Cdk5/p35. Cdk5 and calcineurin are implicated in the
interaction of phosphatidylinositol 4-phosphate 5-kinase
γ661 (PIP5Kγ661) and the clathrin adaptor protein
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Figure 5 Impaired basal synaptic transmission and LTD induction in CreER-p35 cKO mice. (A, B) Input-output relationship. The slope of
field excitatory postsynaptic potentials (fEPSPs) was significantly reduced in CreER-p35 cKO mice (control: n =17 slices [N =9 mice], p35 cKO:
n =10 [N =5]) (A) with no change in presynaptic fiber volley amplitude (PSFV) (B) when compared with controls. *p < 0.05, unpaired t-test.
(C) Synaptic facilitation in response to paired-pulses with an inter-stimulus interval (ISI) of 25–400 ms (control: n =17 [N =9], p35 cKO: n =10
[N =5]). (D) Long-term depression (LTD) induced by low-frequency stimulation (LFS, 1 Hz) combined with the application of the glutamate
transporter blocker, tPDC. LTD was significantly impaired in CreER-p35 cKO mice when compared with controls. Insets are representative traces
before and after LTD induction (control: n =7 [N =4], p35 cKO: n =8 [N =4]). (E) Long-term potentiation (LTP) induced by 3× theta-bust stimulation
(3× TBS). LTP was comparable between genotypes. Insets are representative traces before and after LTP induction (control: n =17 [N =9], p35 cKO:
n =10 [N =5]). Data represent mean ± S.E.M.
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phorylation/dephosphorylation balance of PIP5Kγ661 is
impaired, internalization of AMPA receptors in LTD will
be compromised in the hippocampal CA1 of p35 cKO
mice. The dephosphorylation of cofilin is required for
NMDA receptor-dependent LTD in the CA1 [22].
Furthermore, the phosphorylation of cofilin is upregu-
lated by the treatment of a Cdk5 inhibitor, suggesting
that Cdk5 regulates NMDA receptor-dependent LTD
in the hippocampal CA1 through cofilin [23]. In
addition, Cdk5/p35 phosphorylates a number of postsynap-
tic proteins, including PSD-95 [8], Polo-like kinase 2
[24], NMDA receptors [9], and calcium channels.
Reduced phosphorylation of these proteins may affect
LTD induction. These possibilities should be tested in
future experiments.Cdk5 is involved in dendritic spine formation through
the phosphorylation of ephexin1, WAVE1, and TrkB
[12,25,26]. EphA4, which is activated by the phosphorylation
of ephexin1 by Cdk5, is also necessary for synaptic plasticity
in the amygdala [27]. Another study suggests that the
phosphorylation of TrkB by Cdk5 is required for
spatial memory and hippocampal LTP [12]. These studies
reveal that spine formation, memory formation, and
synaptic plasticity are closely related to each other.
Our analysis of p35 cKO mice also identified reduced
dendritic spines in pyramidal neurons in the cerebral
cortex and hippocampal CA1 region (Figure 4). Therefore,
defective synaptic plasticity, in addition to a reduction in
spine density, is related to the behavioral changes that we
observed in p35 cKO mice. It is also possible that the loss
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Figure 6 Phosphorylation levels of GluR1 in CreER-p35 cKO mice. Western blots of (A) p35, pGluR1 (S845), GluR1 and NR2B, (B) pGluR1
(S831) and GluR1 (C) pCaMKII (T286), pCaMKII (T305) and CaMKII, (D) pCREB (S133) and CREB in the hippocampi of CreER-p35 cKO mice (n =4)
and control (n =4). pGluR1 (S845, S831) are normalized to GluR1, pCREB (S133) normalized to CREB, and others normalized to actin. The phosphorylation
level of pGluR1 (S845) does not change notably, but pGluR1 (S831) is significantly increased in CreER-p35 cKO (p35 cKO) when compared with p35-flox
(control) mice. In CreER-p35 cKO mice, the phosphorylation level of pCaMKII (T286) is significantly increased in comparison with p35-flox mice. The
phosphorylation of pCREB (S133) is not altered between the two genotypes. Error bars represent S.E.M. Unpaired t-test, *p< 0.05, **p< 0.01, ***p< 0.001.
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CreER-p35 cKO mice is lower than that in control mice
(Figure 5), as fewer dendritic spines on CA1 pyramidal
neurons leads to decreased postsynaptic responses [28].
Reduction of dendritic spine densities of CA1 pyramidal
neurons seems cell-autonomous because we observed
similar reduction of spine density of these neurons in
CA1-specific p35 cKO mice [29].
The GluR1 subunit is essential for LTP in the CA1 region
of the adult hippocampus [30]. The phosphorylations of
GluR1 at two sites, S831 by CaMKII and PKC and S845 by
PKA, have been demonstrated to play a role in synaptic
AMPA receptor regulation and synaptic plasticity [31,32].Our biochemical analysis revealed elevated phosphorylation
of GluR1 at S831, but not at S845, in hippocampal homoge-
nates from CreER-p35cKO mice (Figure 6). We also found
elevated phosphorylation of CaMKIIα at T286 (Figure 6),
suggesting an activated state of CaMKIIα [33,34]. Previous
studies have demonstrated the interaction between p35 and
CaMKIIα [35] and elevated phosphorylation of CaMKIIα at
T286 with the Cdk5 inhibitor, roscovitine [36]. Therefore,
our results indicate that loss of p35 releases its inhibitory
function on CaMKIIα and results in elevated phosphoryl-
ation of GluR1 at S831 (Figure 6). These biochemical
changes may explain the lower LTP induction threshold
observed in p35 KO mice [37]. Although the role of
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ized, much less is known about its role in LTD. Pi et al.
have reported that activated CaMKII can promote either
LTP or LTD depending on T305/T306 phosphorylation
[18]. Interestingly, we found a reduction of T305 phosphor-
ylation of CaMKIIα in hippocampal homogenates from
CreER-p35cKO mice (Figure 6). This phosphorylation
site of CaMKIIα inhibits its kinase activity [38,39],
suggesting an activated state of CaMKII. Phosphorylation
of CaMKIIα at S567 has recently been implicated in LTD
[40]. Thus, the relation between CaMKII activation and
LTD induction warrants further investigation.
p25 is formed by the truncation of the N-terminus
of p35 by calpain, and it activates Cdk5 by complexing
with it to form Cdk5/p25. In previous studies, both over-
expression and loss of p25 in the forebrain led to neuronal
loss and neuroinflammation [4,41]. Thus, tight regulation
of Cdk5 is necessary to further study higher brain func-
tion without neuronal loss and neuroinflammation. In
order to exclude the possibility that neuronal loss and
neuroinflammation are the causes of this phenotype,
Cdk5 cKO mice that were generated previously should
be re-evaluated from the viewpoint of neuronal loss
and neuroinflammation. Importantly, in our study,
loss of Cdk5/p35 results in a disturbance of synaptic
plasticity without neuronal loss and neuroinflammation
(Additional file 3: Figure S3).
In a recent study, the impairment of neurotransmitter
release was observed in a forebrain-specific Cdk5 cKO,
indicating defective presynaptic function with Cdk5
loss-of-function [42]. Therefore, we need to dissect
the separate pre- and postsynaptic functions of Cdk5.
As for postsynaptic function, we recently generated
L7cre-p35 cKO mice, in which p35 is dramatically reduced
in Purkinje cells in the cerebellum, and LTD induction
was severely impaired in these Purkinje cells [43]. The
investigation into the role of Cdk5/p35 in postsynaptic
plasticity in the hippocampus by using CA1 specific cre
mice will provide further insight into the role of Cdk5 on
synaptic plasticity in vivo.
The phosphorylation of various substrates by Cdk5
crucially affects synaptic plasticity, spine morphology,
and memory formation, ultimately influencing behavior.
It remains to be elucidated how Cdk5 controls different
forms of neural plasticity via its phosphorylation of diverse
proteins. Our findings on the role of Cdk5/p35 in LTD in
the hippocampus allow a better understanding of the
molecular mechanisms underlying synaptic plasticity
and memory formation.
Conclusions
To investigate the role of Cdk5/p35 in higher brain function
without histological abnormalities, we generated CreER p35
cKO mice. CreER-p35 cKO mice exhibited defective spatiallearning and memory. Our analyses also revealed reduced
spine density of pyramidal neurons, reduced sensitivity
to synaptic input, and impaired LTD induction in
hippocampal CA1. These results indicate that the kinase
function of Cdk5/p35 is essential for normal synaptic
function, and spatial learning and memory.Methods
Materials
Tamoxifen (Sigma, MO) was dissolved in 99.9% methanol
in 100 mg ·ml−1, where DMSO was added (99.9% methanol:
DMSO =5:2). 10 mg · ml−1 solution was made in corn
oil (Sigma, MO).Generation of tamoxifen-induced p35 conditional KO
mice
All experimental protocols were approved by Institutional
Animal Care and Use Committees of Waseda University
and RIKEN. Throughout the experimental procedures, all
efforts were made to minimize the number of animals
used and their suffering. Mice were fed ad libitum with
standard laboratory chow and water in standard animal
cages under a 12 h light/dark cycle.
p35-flox mice were generated as described on a
C57BL/6 background [43]. CAGGCre-ER (CreER) mice
[17] were obtained from Jackson laboratory (stock number
004682). By crossing p35flox/+ and CreER mice, p35-flox/
flox; CreER mice were obtained. Cre activity was induced
by oral administration of tamoxifen (3 mg · 40 g−1
body weight in corn oil) daily for three days. The resultant
inducible p35 conditional KO mice were used as CreER-p35
cKO mice along with littermate controls that were given
same tamoxifen treatment.Biochemical analysis
Hippocampi of the mice were collected from p35
cKO mice (n =4) and their p35-flox littermates (n =4)
as controls at 6 months old. Western blotting analysis
was conducted as previously described [44]. Primary
antibodies used in present study are as follows; polyclonal
antibody against p35 (C-19, 1:1000, Santa Cruz), anti-NR2B
(1:1000, Cell signaling technology), anti-CREB (1:1000, Cell
signaling technology), anti-pCREB (S133, 1:1000, Cell
signaling technology), anti-GluR1 (1:1000, Cell signaling
technology), anti-pGluR1 (S831/S845, 1:1000, Upstate),
anti-CaMKII (1:1000, Chemicon), anti-pCaMKII (T286,
1:1000, Cell signaling technology), anti-pCaMKII (T305,
1:1000, Upstate) and anti-actin (1:1000, Sigma). Statistical
analysis was conducted using the Student’s t test and
mean ± standard error of the mean (S.E.M.) are shown on
the graph. p < 0.05 was considered to be statistically
significant.
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For modified Golgi–Cox staining, an FD Rapid Golgi Stain
kit was used according to manufacturer’s instructions (FD
NeuroTechnologies, MD). Stained slices were sectioned at
a thickness of 150 μm. Pyramidal neurons of hippocampal
CA1 and layer V in cerebral cortex from each mouse were
selected and the number of spines in apical dendrites of
the neurons in hippocampal CA1 and in basal dendrites
of the neurons in layer V in the cerebral cortex were
counted using a BX50 microscope (Olympus, Japan)
with UPlanSApo 40× (NA =0.95) objective. In a typical
experiment, over 2000 spines were counted on more than
50 dendritic segments in 25 neurons for each sample.
Statistical analysis was conducted by the Student’s t test,
and the mean ± S.E.M. are shown on the graph. p < 0.05
was considered to be statistically significant.
Electrophysiology
Slice preparation
Electrophysiological experiments were conducted with
2–2.5 month-old male mice 2–5 weeks after oral admin-
istration of tamoxifen. Mice were deeply anesthetized with
halothane (2-Bromo-2-chloro-1, 1, 1-trifluoroethane) and
killed by decapitation. The brains were immediately
removed and placed in an ice-cold cutting solution
[containing (in mM) sucrose 200, KCl 3, NaH2PO4 1,
MgSO4 10, CaCl2 0.2, NaHCO3 26, and D-glucose 10,
saturated with 95% O2 and 5% CO2]. Transverse hippo-
campal slices (300 μm thick) were prepared from both
hemispheres. The slices were incubated in the record-
ing solution [containing (in mM) NaCl 120, KCl 3,
NaH2PO4 1, MgSO4 1.25, CaCl2 2.5, NaHCO3 26, and
D-glucose 10, saturated with 95% O2 and 5% CO2] at
room temperature (25°C) for at least 1 h before recording.
Extracellular recordings
Field potential responses were recorded from the stratum
radiatum area in the CA1, using an array of 64 planar
microelectrodes (MED-P515A) arranged in an 8 × 8
pattern with an interelectrode spacing of 150 μm
(Alpha Med Scientific Inc.). Schaffer collaterals were
stimulated at 0.05 Hz by delivering biphasic current
pulses (5–19 μA, 0.2 ms). Input-output relationships were
measured as previously described [44]. For paired-pulse
facilitation (PPF) and long-term potentiation (LTP), the
stimulation intensities were chosen to produce an excita-
tory postsynaptic potential (fEPSP) with 30% amplitude
of the maximal response. The PPF was induced by paired
stimuli with increasing intervals from 25–400 ms. The
facilitation ratio was calculated as described [45]. Long-term
potentiation (LTP) was induced with 3 theta burst stimula-
tions at 0.05 Hz after 20 min of stable baseline recording.
Each theta burst consisted of 4 bursts (5 Hz), each of
which consisted of 4 pulses (100 Hz). LTP was recordedfor 60 min after induction, and the potentiation was evalu-
ated with the average slope of the last 5 min recording
(56–60 min). For long-term depression (LTD), the stimula-
tion intensities were chosen to produce a fEPSP with 50%
amplitude of the maximal response. LTD was induced by
low frequency stimulation (1 Hz, 1800 s) in the presence
of glutamate transporter inhibitor L-trans-pyrrolidine-
2,4-dicarboxylic acid (tPDC, 300 μM) [19]. LTD was re-
corded for 60 min after induction, and the depression was
evaluated with the average slope of the last 5 min recording
(56–60 min). In a separate experiment examining if the
LTD was NMDA receptor (NMDAR)-dependent, the
NMDAR antagonist D-AP5 (50 μM) was co-applied with
tPDC. Evoked field responses were, through a 0.1–10 kHz
bandpass filter, recorded at a 20 kHz sampling rate and
stored for off-line analysis. All data were acquired and
analyzed with a MED64 Mobius (Alpha Med Scientific
Inc.). All experiments were performed by an investigator
blind to the mouse genotype. Student’s t test was used for
statistical analysis.
Behavioral analysis
All experiments were performed by an investigator blind to
the mouse genotype; 3 mg · 40 g−1 body weight tamoxifen
was given orally for three days to p35-flox and p35-flox;
CreER male mice. After two weeks, 5–5.5 month old male
mice were subjected to behavioral analysis as described
below (p35-flox: n = 6, CreER-p35 cKO: n = 7). Student’s
t-test and one-way/two-way ANOVAs were used for
statistical analysis.
Open field
The locomotor activity of each mouse was assessed with
an open field (60 × 60 cm) at 55 lx for 30 min. The mice
were placed in the center of the area, and their horizontal
movements were registered with a set of cameras and
analyzed with TimeOFCR4 software [46].
Elevated plus maze test
The elevated plus maze apparatus was set at a height of
50 cm above the floor with 4 gray plexiglass arms, which
were 2 opposite open arms (25 cm× 5 cm) and 2 opposite
closed arms (25 cm× 5 cm× 15 cm). The apparatus was
brightly illuminated (250 lx) at the surface of each arm.
Every mouse was placed in the center of the apparatus;
their movement was measured for 10 min, and analyzed
with TimeEP1 software [46].
Morris water maze test
The Morris water maze test was performed as previously
described with some modifications [47]. In this study,
we used a pool with diameter of 150 cm. A circular
platform (10 cm in diameter) submerged ~0.7 cm below
the water surface was placed 37.5 cm from the center of
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balancing samples. Mice were given 4 trials per day for 7
consecutive days in the hidden platform task under
brightly illuminated conditions (250 lx at the surface of
maze). A randomly selected starting point along the rim
of the maze was used for each of the four trials. A probe
test was performed on day 8 after the acquisition session.
In the probe test, the platform was removed from the tank
and each mouse was allowed to swim for 60 s. On
day 10, mice were tested in a visible platform task for
3 consecutive days. In the visible platform task, the
platform was made visible by attaching a black cubic
landmark to the platform. Mouse movement in the
water maze was recorded by a video camera and analyzed
using NIH image WM software (O’Hara & Co.).
Statistics
The data are presented as mean ± S.E.M., unless otherwise
noted. The statistical analyses were performed using the
Student’s t test, one-way ANOVA, or two-way repeated
measures ANOVA as described in the Results or in
the Figure legends. p < 0.05 was considered statistically
significant.
Additional files
Additional file 1: Figure S1. No changes of Cdk5 protein levels in
hippocampal homogenates from CreER-p35 cKO mice. Western blot
analysis of Cdk5 protein in hippocampal homogenates from control and
CreER-p35 cKO mice (p35 cKO) with anti-Cdk5 and anti-actin antibodies
(A). No difference was found in Cdk5 protein levels among two
genotypes (B). n = 4.
Additional file 2: Figure S2. NMDA receptor-dependent LTD induction
in the presence of tPDC. LTD induced by LFS in the presence of 300 μM
tPDC was significantly blocked by application of D-AP5.Hippocampal
slices from wild-type animals (C57BL/6 J) were used.
Additional file 3: Figure S3. No neuro-inflammation in hippocampal
CA1 in CreER-p35 cKO mice. Immunostaining of hippocampal sections of
control and CreER-p35 cKO mice (p35 cKO) with Iba1 to observe activated
microglia (A), with GFAP to observe activated astrocytes (B) and with DAPI.
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